ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This study is designed to characterize the early effects of ApoA-I synthesis with RVX000222
on coronary atherosclerotic disease when administered to patients with coronary artery
disease and have a low HDL-C level, as assessed by Intravascular Ultrasound (IVUS) in
addition to standard background therapy.